Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Partner4Exercise Randomized Controlled Trial

Study ID: NCT07408128
Start Date: 2026-05-01
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

183

Intervention / Treatment

Peer matching

Quailfied Exercise Professional (QEP) Support

Sponsor

McMaster University

Source: clinicaltrials.gov

Share:
Add to list

Overdose Prevention Centers and Behavioral Health

Study ID: NCT06236087
Start Date: 2026-09-01
End Date: 2027-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Neuromodulation Strategies for Treatment-Resistant Essential Tremor Using Chronos™ DBS

Study ID: NCT07302867
Start Date: 2026-04-01
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5

Intervention / Treatment

Continuous

Continuous + High Frequency Cycling

High Frequency

Microburst

Scheduling

Cycling

Sponsor

University of British Columbia

Source: clinicaltrials.gov

Share:
Add to list

Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis

Study ID: NCT04670965
Start Date: 2026-04
End Date: 2028-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

E-PRF/rhBMP-2 (similar ratios)

E-PRF/ACS/rhBMP-2

rhBMP-2/E-PRF

E-PRF only

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Safety and Pharmacokinetics of Rescue Liposome in Healthy Adults

Study ID: NCT07375498
Start Date: 2026-08-20
End Date: 2027-02-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

liposome dispersion

Sponsor

Cristália Produtos Químicos Farmacêuticos Ltda.

Source: clinicaltrials.gov

Share:
Add to list

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Study ID: NCT06303193
Start Date: 2026-03-30
End Date: 2035-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

pacritinib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Photobiomodulation, Heart Rate Variability, and Acute Stress

Study ID: NCT07475858
Start Date: 2026-04-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Vielight Vagus

Sham Vielight Vagus

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Weight Gain in Pediatric Leukemia Survivors

Study ID: NCT07374315
Start Date: 2026-03-31
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Modified Guided Self-Help Family Intervention

NIH Educational Resources

FitBit Ace

WashU Extended Learning Canvas

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness and Security Testing of a Mobile App

Study ID: NCT04519008
Start Date: 2026-10-01
End Date: 2028-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Mobile app

Treatment as usual

Sponsor

Consorcio Sanitari del Maresme

Source: clinicaltrials.gov

Share:
Add to list

Structural and Intermediary Social Determinants of Oral Health Among Egyptian Women

Study ID: NCT04138550
Start Date: 2027-12-01
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

Misr International University

Source: clinicaltrials.gov

Share:
Add to list